Clinical trials in Pozzuoli – page 47

Clinical trial activity in Località la Schiana, Pozzuoli is strongly focused on cancer research, with studies examining how to improve treatment options for several advanced solid tumors. The main goal is to test new therapeutic strategies and refine existing combinations for better disease control and patient outcomes.

• Colorectal cancer, including metastatic and unresectable forms
• Metastatic castration-resistant prostate cancer
• Metastatic renal cell carcinoma
• Breast cancer with hormone receptor-positive, HER2-negative disease

These studies are exploring more effective ways to slow progression, overcome treatment resistance, and improve survival in patients with advanced neoplasms.

Several trials in this site concentrate on digestive system cancers, especially advanced colorectal cancer. Research is centered on evaluating treatment effectiveness and finding better options for patients whose disease has already progressed or carries specific genetic changes.

• RAS-mutant metastatic colorectal cancer
• RAS/BRAF wild-type metastatic colorectal cancer
• Unresectable left-sided metastatic colorectal cancer
• Patients with metastatic colorectal cancer

Across these studies, the focus is on improving tumor response, extending disease control, and identifying which patients may benefit most from targeted treatment approaches.

This research landscape also includes therapeutic techniques aimed at improving how treatments are delivered and how response is monitored. The trials are not only testing active therapies, but also looking for better ways to understand resistance, safety, and treatment benefit in real-world patients.

• Biomarker research for resistance and treatment monitoring
• Safety and tolerability comparisons between treatment strategies
• Quality of life assessments during therapy
• Therapy optimization in advanced cancer care

In this part of the research portfolio, investigators in Pozzuoli are helping shape more precise and patient-centered cancer care.